Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial-Reference-Cited by-同舟云学术

Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial

Published:2022-08 Issue:5 Volume:113 Page:1063-1071
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Liu Xu,Guo Ling,Xie Fang-Yun,Hu Wei-Han,Chen Ming-Yuan,He Qing-Mei,Xu Zhi-Min,Zhang Chu-Qing,Peng Ying-Lin,Tang Ling-Long,Mao Yan-Ping,Sun Rui,Li Ji-Bin,Argiris Athanassios,Hui Edwin P.,Sun Ying,Ma Jun

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference35 articles.

1. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration;Feinmesser;N Engl J Med,1992

2. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma;Lo;Cancer Res,1999

3. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma;Lin;N Engl J Med,2004

4. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer;Chan;N Engl J Med,2017

5. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma;Chan;J Natl Cancer Inst,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Angiogenesis Signal Pathway and Antiangiogenic Drugs in Nasopharyngeal Carcinoma;Current Molecular Pharmacology;2024-05-17

2. Residual plasma Epstein–Barr virus DNA after intensity-modulated radiation therapy is associated with poor outcomes in nasopharyngeal carcinoma;Future Oncology;2023-11-01

3. Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial;Nature Communications;2023-08-14

4. Targeted therapy for head and neck cancer: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-01-16

5. Efficacy and safety of low concentration hydrogen peroxide as nasopharyngeal lavage fluid in the treatment for nasopharyngeal carcinoma radiotherapy: a pilot cohort study;Journal of Cancer;2023